SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Neptune Technologies & Bioressources Inc. – ‘6-K’ for 11/14/17 – ‘EX-99.3’

On:  Tuesday, 11/14/17, at 4:13pm ET   ·   For:  11/14/17   ·   Accession #:  1171843-17-6995   ·   File #:  1-33526

Previous ‘6-K’:  ‘6-K’ on / for 11/14/17   ·   Next:  ‘6-K’ on / for 11/27/17   ·   Latest:  ‘6-K’ on / for 3/14/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/14/17  Neptune Techs & Bioressources Inc 6-K        11/14/17    5:1.1M                                   Globenewswire Inc./FA

Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report by a Foreign Private Issuer                  HTML     11K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    177K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML    391K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML     11K 
 5: EX-99.4     Miscellaneous Exhibit                               HTML     10K 


EX-99.3   —   Miscellaneous Exhibit


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 99.3

 

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

 

I, James S. Hamilton, Chief Executive Officer of Neptune Technologies & Bioressources Inc., certify the following:

 

1.Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Neptune Technologies & Bioressources Inc. (the “issuer”) for the interim period ended September 30th, 2017.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4.Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in Regulation 52-109 respecting Certification of Disclosure in Issuers’ Annual and Interim Filings (c. V-1.1, r.27), for the issuer.

 

5.Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

 

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

(i)material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii)information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the COSO (Committee of Sponsoring Organizations in the Treadway Commission) Internal Controls – Integrated Framework.

 

5.2– N/A

 

5.3– N/A

 

6.Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1st, 2017 and ended on September 30th, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: November 14, 2017

 

 

/s/ James S. Hamilton

 

James S. Hamilton

Chief Executive Officer

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period End:11/14/176-K
 List all Filings 
Top
Filing Submission 0001171843-17-006995   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 11:23:25.1pm ET